First Tracks Biotherapeutics, Inc. (TRAX)
NASDAQ: TRAX · Real-Time Price · USD
41.86
-2.88 (-6.44%)
At close: Aug 28, 2026, 4:00 PM EDT
42.59
+0.73 (1.75%)
After-hours: Aug 28, 2026, 7:47 PM EDT

TRAX Statistics

Total Valuation

TRAX has a market cap or net worth of $1.50 billion. The enterprise value is $1.33 billion.

Market Cap1.50B
Enterprise Value 1.33B

Important Dates

The last earnings date was Wednesday, August 12, 2026, after market close.

Earnings Date Aug 12, 2026
Ex-Dividend Date n/a

Share Statistics

TRAX has 35.73 million shares outstanding.

Current Share Class 35.73M
Shares Outstanding 35.73M
Shares Change (YoY) n/a
Shares Change (QoQ) +0.32%
Owned by Insiders (%) 1.83%
Owned by Institutions (%) 76.11%
Float 26.15M

Valuation Ratios

PE Ratio n/a
Forward PE n/a
PS Ratio n/a
Forward PS n/a
PB Ratio 8.78
P/TBV Ratio 8.86
P/FCF Ratio n/a
P/OCF Ratio n/a
PEG Ratio n/a
Financial Ratio History

Enterprise Valuation

EV / Earnings n/a
EV / Sales n/a
EV / EBITDA n/a
EV / EBIT n/a
EV / FCF n/a

Financial Position

The company has a current ratio of 14.28, with a Debt / Equity ratio of 0.03.

Current Ratio 14.28
Quick Ratio 13.91
Debt / Equity 0.03
Debt / EBITDA n/a
Debt / FCF n/a
Interest Coverage n/a

Financial Efficiency

Return on Equity (ROE) n/a
Return on Assets (ROA) n/a
Return on Invested Capital (ROIC) n/a
Return on Capital Employed (ROCE) -99.35%
Weighted Average Cost of Capital (WACC) n/a
Revenue Per Employee n/a
Profits Per Employee -$1.54M
Employee Count 104
Asset Turnover n/a
Inventory Turnover n/a

Taxes

Income Tax n/a
Effective Tax Rate n/a

Stock Price Statistics

Beta (5Y) n/a
52-Week Price Change n/a
50-Day Moving Average 35.68
200-Day Moving Average n/a
Relative Strength Index (RSI) 49.97
Average Volume (20 Days) 553,764

Short Selling Information

The latest short interest is 3.89 million, so 10.89% of the outstanding shares have been sold short.

Short Interest 3.89M
Short Previous Month 3.96M
Short % of Shares Out 10.89%
Short % of Float 14.88%
Short Ratio (days to cover) 5.33

Income Statement

Revenue n/a
Gross Profit n/a
Operating Income -169.58M
Pretax Income -160.30M
Net Income -160.30M
EBITDA -169.08M
EBIT -169.58M
Earnings Per Share (EPS) -$4.53
Full Income Statement

Balance Sheet

The company has $168.02 million in cash and $4.33 million in debt, with a net cash position of $163.69 million or $4.58 per share.

Cash & Cash Equivalents 168.02M
Total Debt 4.33M
Net Cash 163.69M
Net Cash Per Share $4.58
Equity (Book Value) 168.80M
Book Value Per Share 4.77
Working Capital 165.30M
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -$123.76 million and capital expenditures -$55,000, giving a free cash flow of -$123.82 million.

Operating Cash Flow -123.76M
Capital Expenditures -55,000
Depreciation & Amortization 501,000
Net Borrowing n/a
Free Cash Flow -123.82M
FCF Per Share -$3.47
Full Cash Flow Statement

Margins

Gross Margin n/a
Operating Margin n/a
Pretax Margin n/a
Profit Margin n/a
EBITDA Margin n/a
EBIT Margin n/a
FCF Margin n/a

Dividends & Yields

TRAX does not appear to pay any dividends at this time.

Dividend Per Share n/a
Dividend Yield n/a
Dividend Growth (YoY) n/a
Years of Dividend Growth n/a
Payout Ratio n/a
Buyback Yield n/a
Shareholder Yield n/a
Earnings Yield -10.72%
FCF Yield -8.28%

Analyst Forecast

The average price target for TRAX is $69.44, which is 65.89% higher than the current price. The consensus rating is "Strong Buy".

Price Target $69.44
Price Target Difference 65.89%
Analyst Consensus Strong Buy
Analyst Count 9
Revenue Growth Forecast (3Y) n/a
EPS Growth Forecast (3Y) n/a
Stock Forecasts

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value n/a
Lynch Upside n/a
Graham Number n/a
Graham Upside n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date n/a
Split Type n/a
Split Ratio n/a

Scores

Altman Z-Score n/a
Piotroski F-Score 1